Legend Biotech Corp ADR (LEGN)

Industry Biotechnology


This stock can be held in an Investment Account
Sell

$26.90

Buy

$27.50

arrow-down$-0.57 (-2.07%)

Prices updated at 18 May 2026, 09:42 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. Fangliang Frank Zhang, PhD
CEO
Dr. Ying Huang, PhD
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
2,900
Head office
2101 Cottontail Lane
Somerset
United States
08873
mobile
+1 737 317-5050
letter
-

Key personnel

Salary
Mr. Gareth Kung
Independent Director
-
Dr. Corazon Dating Sanders, PhD
Independent Director
-
Dr. Ying Huang, PhD
Director and Chief Executive Officer
-
Dr. Fangliang Frank Zhang, PhD
Chairman of the Board
-
Ms. Ye Wang, M.S.
Director
-
Dr. Darren Xiaohui Ji, M.D.,PhD
Independent Director
-
Mr. Tomas J. Heyman
Independent Director
-
Dr. Patrick Casey, PhD
Independent Director
-
Mr. Jiange Robin Meng
Director
-
Dr. Li Mao, M.D.
Independent Director
-
Dr. Peter Salovey, PhD
Lead Independent Director
-
Mr. Carlos Santos Garcia
Chief Financial Officer
-

Top 5 shareholders

No. of shares
FMR Inc24,268,223
Fidelity Management and Research Company24,268,223
Fidelity Management & Research Company LLC14,161,536
Suvretta Capital Management, LLC7,581,029
Hillhouse Capital Advisors, Ltd.5,984,550

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.